Scott Becker ^Investor

Scott Becker is an accomplished biotech entrepreneur and computer scientist with a strong focus on innovating in the field of drug discovery. As Co-Founder and Chief Business Officer of Delve Therapeutics, Scott has been integral in developing novel cancer therapies since 2016. His prior role as VP of Enterprise Products at Schrodinger, Inc. from 2012 to 2016, emphasized his knack for leveraging computer-assisted technologies to enhance small molecule drug development, resulting in impactful collaborations like those with Nimbus Therapeutics and Morphic Therapeutic. Notably, Scott's earlier venture, Invite Media, was a computational advertising company that he co-founded and led as CTO until its acquisition by Google in 2010. Scott holds a degree in Computational Biology from the University of Pennsylvania and has been recognized with a patent for a collaborative drug discovery system. His professional journey is marked by a commitment to integrating advanced computational tools into practical applications that advance scientific discovery and development.